RecruitingNCT07490197

Acute Subdural Hematoma

Acute Subdural Hematoma Registry


Sponsor

Methodist Health System

Enrollment

100 participants

Start Date

Feb 1, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

This retrospective data repository will serve as a means to aggregate and analyze standard surgical interventions and Middle Meningeal Arteryembolization as suitable treatment options for Acute Subdural Hematoma.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • ≥18 years old
  • Included in the Methodist Dallas Medical Center Trauma Registry
  • Acute subdural hematoma identified on computed tomography scan or magnetic resonance imaging of the brain in the trauma bay within 72 hours of a traumatic event

Exclusion Criteria2

  • \<18 years old
  • Prisoners, pregnant persons, or other protected population

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERMedical/Phenotype Data Collection Procedures & Data to be Collected

TheMethodist Dallas Medical Center Trauma Registry will be queried for demographic information, diagnosis codes, admission dates, traumatic injury characteristics, surgical procedures, comorbidities, inpatient outcomes, complications, consultations, discharge location, and mortality. Additional laboratory values will be abstracted from Epic through retrospective chart review.


Locations(1)

Methodist Dallas Medical Center- Clinical Research Institute

Dallas, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07490197


Related Trials